Skip to main content
Feedback to SSRN
Feedback
(required)
Email
(required)
Submit
Peng Chuang
Central South University - Hunan Provincial Tumor Hospital and the Affiliated Tumor Hospital
Learn more about SSRN Profiles
SCHOLARLY PAPERS
1
DOWNLOADS
49
TOTAL CITATIONS
0
Feedback
Scholarly Papers (1)
Sort by:
Paper Title, A-Z
Paper Title, Z-A
Author Name, A-Z
Author Name, Z-A
Date Posted, Ascending
Date Posted, Descending
Downloads, Ascending
Downloads, Descending
Citations, Ascending
Citations, Descending
Actions:
Email selected abstracts
View:
Selected
Original List
All Versions
Hide All Versions
All Abstracts
Hide All Abstracts
1.
Patient-Reported Outcomes Regarding the Safety and Management of Immunotherapy in Primary Liver Cancer: A National Cross-sectional Study (CLEAP 005)
Number of pages: 24
Posted: 05 Nov 2025
Tang Yu-Hao
,
Du Shun-Da
,
Yang Xin-Rong
, Peng Chuang,
Liu Xiu-Feng
,
Guo Wen-Zhi
,
Gao Liang-Hui
,
Zhao Hai-Tao
,
Sun Hui-Chuan
and
Xu Li
Sun Yat-sen University (SYSU), Chinese Academy of Medical Sciences & Peking Union Medical College (CAMS & PUMC) - Peking Union Medical College Hospital, Fudan University - Department of Liver Surgery, Central South University - Hunan Provincial Tumor Hospital and the Affiliated Tumor Hospital, Nanjing University - Nanjing Jinling Hospital, Zhengzhou University - Department of Hepatobiliary and Pancreatic Surgery, Hainan Medical University, Chinese Academy of Medical Sciences & Peking Union Medical College (CAMS & PUMC) - Department of Liver Surgery, Fudan University - Department of Liver Surgery and Sun Yat-sen University (SYSU) - State Key Laboratory of Oncology in South China
Downloads
49
View PDF
Download
Abstract:
Liver cancer, immunotherapy, adverse events, quality of life, patient-reported outcomes
Feedback